| 000 | 01921 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514024720.0 | ||
| 264 | 0 | _c20020325 | |
| 008 | 200203s 0 0 eng d | ||
| 022 | _a0148-916X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCosta, M B | |
| 245 | 0 | 0 |
_aDistinct histopathological patterns in single lesion leprosy patients treated with single dose therapy (ROM) in the Brazilian Multicentric Study. _h[electronic resource] |
| 260 |
_bInternational journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association _cSep 2001 |
||
| 300 |
_a177-86 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHistocytochemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeprostatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aLeprosy, Lepromatous _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMinocycline _xtherapeutic use |
| 650 | 0 | 4 |
_aMycobacterium leprae _xgrowth & development |
| 650 | 0 | 4 |
_aNeuritis _xpathology |
| 650 | 0 | 4 |
_aOfloxacin _xtherapeutic use |
| 650 | 0 | 4 |
_aRifampin _xtherapeutic use |
| 700 | 1 | _aCavalcanti Neto, P F | |
| 700 | 1 | _aMartelli, C M | |
| 700 | 1 | _aStefani, M M | |
| 700 | 1 | _aMaceira, J P | |
| 700 | 1 | _aGomes, M K | |
| 700 | 1 | _aSchettini, A P | |
| 700 | 1 | _aRebello, P F | |
| 700 | 1 | _aPignataro, P E | |
| 700 | 1 | _aUeda, E S | |
| 700 | 1 | _aNarahashi, K | |
| 700 | 1 | _aScollard, D M | |
| 773 | 0 |
_tInternational journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association _gvol. 69 _gno. 3 _gp. 177-86 |
|
| 999 |
_c11782932 _d11782932 |
||